Focus on Serotonin Uptake Inhibitor Research

The most significant class of antidepressants marketed is the selective serotonin re-uptake inhibitors (SSRIs). Claims of decreased adverse effects (ADRs) and increased safety have led to extensive use of these drugs by non-psychiatrists. This book presents research from throughout the world on this topic.